- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Poly IC
Total 1411 results
-
Hospital Clinic of BarcelonaInstituto de Salud Carlos IIICompletedArtificial Intelligence | Colonoscopy | Colorectal Polyp | Histology | Hyperplastic Polyp | Computer-aided Diagnosis | Adenoma Colon PolypSpain
-
Ibrahim Halil SahinGlaxoSmithKlineNot yet recruitingMMR-D/MSI-H Colorectal CancersUnited States
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineRecruitingPenile CarcinomaUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
Tesaro, Inc.Completed
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
AstraZenecaCompletedAdvanced Solid TumorsUnited States, Spain
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingHead and Neck Neoplasms | Carcinoma, Squamous Cell | Laryngeal Cancer Stage II | Laryngeal Cancer Stage IIINetherlands
-
zr Pharma & GmbHCompletedAdvanced Solid TumorsUnited Kingdom
-
University of Alabama at BirminghamWithdrawnOvarian Cancer RecurrentUnited States
-
Geoffrey Shapiro, MD, PhDEli Lilly and Company; AstraZenecaCompletedSolid TumorUnited States
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsUnited States, Canada
-
National Cancer Institute (NCI)Terminated
-
Ruijin HospitalUnknownStomach Cancer | Gastric CancerChina
-
Yardley Dermatology AssociatesGalderma R&DCompletedFacial Volume Loss
-
AstraZenecaCompletedSolid TumoursBelgium, France, Netherlands, United Kingdom, Denmark
-
Rockefeller UniversityCompletedHealthy VolunteersUnited States
-
RTI InternationalNational Institute of Mental Health (NIMH)CompletedHIV Infections | Sexually Transmitted DiseasesPeru, Russian Federation, China, India, Zimbabwe
-
Technical University of MunichFraunhofer Institut ErlangenUnknown
-
Rutgers, The State University of New JerseyUnknownBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Cancer | Melanoma (Skin) | Liver CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage I Uterine Corpus Cancer AJCC v8United States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedRecurrent MelanomaUnited States
-
Nova Scotia Health AuthorityTerminatedInterstitial Cystitis | Bladder DiseasesCanada
-
Case Comprehensive Cancer CenterTerminatedStage IV Endometrial Carcinoma | Stage III Endometrial Carcinoma | Stage II Endometrial Carcinoma | Stage I Endometrial CarcinomaUnited States
-
Alberta Children's HospitalThe Hospital for Sick Children; British Columbia Children's Hospital; Stollery...TerminatedShort Bowel Syndrome | Intestinal FailureCanada
-
National Institute of Allergy and Infectious Diseases...AIDS Clinical Trials Group; Acute Infection and Early Disease Research ProgramCompletedHIV InfectionsUnited States, American Samoa, Australia
-
Gliknik Inc.CompletedSquamous Cell Carcinoma of the Oral CavityUnited States, Hungary, Ukraine, Russian Federation, Serbia, Poland, Spain
-
Sun Yat-sen UniversityNot yet recruitingOvarian Cancer | Primary Peritoneal Cancer | High Grade Serous Adenocarcinoma of Ovary | High Grade Endometrioid Ovarian Cancer | Fallopian-tube CancerChina
-
Celldex TherapeuticsTerminatedUnresectable Stage III or Stage IV MelanomaUnited States
-
Zhejiang Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingFemale Breast Cancer Patients | Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer | HRD Positive Advanced Breast Cancer
-
ExelixisRecruitingAdvanced Solid TumorUnited States
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Not yet recruiting
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
National Cancer Institute, NaplesRecruiting
-
AstraZenecaRecruitingOvarian CancerChina, Vietnam, Russian Federation, Ukraine, South Africa, Turkey, India, Peru, Colombia, Poland, Chile, Philippines
-
Xiaoxiang ChenRecruitingOvarian Cancer | PARP Inhibitor | Clinical MarkerChina
-
AZ-VUBAstraZeneca; Kom Op Tegen KankerRecruitingAdvanced Cancers Harbouring Mutations in HRGBelgium
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
M.D. Anderson Cancer CenterAstraZenecaActive, not recruitingMalignant Neoplasms of Female Genital Organs | Malignant Neoplasm of Breast | Malignant Neoplasms of Thyroid and Other Endocrine Glands | Malignant Neoplasms of Digestive Organs | Malignant Neoplasms of Male Genital OrgansUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
BeiGeneCompletedTriple Negative Breast Cancer | Advanced High-grade Ovarian CancerChina
-
Fundacion CRIS de Investigación para Vencer el...GlaxoSmithKline; Apices Soluciones S.L.; IpsenActive, not recruiting
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedMetastatic Adenocarcinoma of the Pancreas | Germline BRCA1/2 Mutations andUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Germany, Korea, Republic of, Australia, Israel, Netherlands
-
zr Pharma & GmbHFoundation MedicineCompletedMetastatic Castration Resistant Prostate CancerUnited States, Spain, United Kingdom, France, Australia, Belgium, Denmark, Israel, Germany, Ireland, Canada, Italy
-
MedSIRTerminated
-
Hospices Civils de LyonCompleted
-
University College, LondonMedivation, Inc.WithdrawnEndometrial CancerUnited Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedGastric CancerUnited States, Korea, Republic of
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZeneca; MedImmune LLCTerminatedPrimary Peritoneal CarcinomaUnited States